BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22936636)

  • 1. The race for interferon-free HCV therapies: a snapshot by the spring of 2012.
    De Clercq E
    Rev Med Virol; 2012 Nov; 22(6):392-411. PubMed ID: 22936636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C therapy in non-genotype 1 patients: the near future.
    Wartelle-Bladou C; Le Folgoc G; Bourlière M; Lecomte L
    J Viral Hepat; 2012 Aug; 19(8):525-36. PubMed ID: 22762136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Direct antiviral treatment strategies in chronic hepatitis C].
    Neumann-Haefelin C; Blum HE; Thimme R
    Dtsch Med Wochenschr; 2012 Jun; 137(25-26):1360-5. PubMed ID: 22653493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid progression of antiviral treatments of chronic hepatitis C virus infection.
    Pol S; Corouge M; Mallet V; Sogni P
    Minerva Gastroenterol Dietol; 2013 Jun; 59(2):161-72. PubMed ID: 23831907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New antiviral therapies in the management of HCV infection.
    Farnik H; Zeuzem S
    Antivir Ther; 2012; 17(5):771-83. PubMed ID: 22626842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus: standard-of-care treatment.
    Pawlotsky JM
    Adv Pharmacol; 2013; 67():169-215. PubMed ID: 23886001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in HCV therapy.
    Kronenberger B; Zeuzem S
    J Viral Hepat; 2012 Jan; 19 Suppl 1():48-51. PubMed ID: 22233414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current race in the development of DAAs (direct-acting antivirals) against HCV.
    De Clercq E
    Biochem Pharmacol; 2014 Jun; 89(4):441-52. PubMed ID: 24735613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of direct-acting antiviral agents for the treatment of chronic hepatitis C.
    Shah N; Pierce T; Kowdley KV
    Expert Opin Investig Drugs; 2013 Sep; 22(9):1107-21. PubMed ID: 23735127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New antivirals against hepatitis C virus].
    Kato N; Muroyama R; Goto K
    Nihon Rinsho; 2012 Apr; 70(4):664-70. PubMed ID: 22568151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic hepatitis C: current and future.
    Pawlotsky JM
    Curr Top Microbiol Immunol; 2013; 369():321-42. PubMed ID: 23463207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapies for hepatitis C: insights from the structure of the virus.
    Fusco DN; Chung RT
    Annu Rev Med; 2012; 63():373-87. PubMed ID: 21942423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs for hepatitis C virus.
    Pockros PJ
    Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):145-54. PubMed ID: 19072442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hepatitis C: treatments of the future.
    Bourlière M; Khaloun A; Wartelle-Bladou C; Oules V; Portal I; Benali S; Adhoute X; Castellani P
    Clin Res Hepatol Gastroenterol; 2011 Dec; 35 Suppl 2():S84-95. PubMed ID: 22248700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The era of direct-acting antivirals has begun: the beginning of the end for HCV?
    Vachon ML; Dieterich DT
    Semin Liver Dis; 2011 Nov; 31(4):399-409. PubMed ID: 22189979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targets for antiviral therapy of hepatitis C.
    Rupp D; Bartenschlager R
    Semin Liver Dis; 2014 Feb; 34(1):9-21. PubMed ID: 24782254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the molecular targets for new therapeutical agents in hepatitis c infection.
    Vagu C; Sultana C; Ruţă S
    Roum Arch Microbiol Immunol; 2013; 72(1):5-24. PubMed ID: 23947011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Directly acting antivirals against hepatitis C virus.
    Soriano V; Vispo E; Poveda E; Labarga P; Martin-Carbonero L; Fernandez-Montero JV; Barreiro P
    J Antimicrob Chemother; 2011 Aug; 66(8):1673-86. PubMed ID: 21652618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New hepatitis C virus (HCV) drugs and the hope for a cure: concepts in anti-HCV drug development.
    Pawlotsky JM
    Semin Liver Dis; 2014 Feb; 34(1):22-9. PubMed ID: 24782255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?
    Halfon P; Sarrazin C
    Liver Int; 2012 Feb; 32 Suppl 1():79-87. PubMed ID: 22212577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.